Povidone

Summary

Povidone (CHEMBL2108139) is an approved unknown; indicated across 3 conditions including blepharitis and viral conjunctivitis.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Unknown
• Indications: 3 conditions
• Clinical trials: 10

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL2108139
Name	Povidone
Type	Unknown
Max phase	4

Also known as: E-1201, INS NO.1201, INS-1201, K30, NSC-114022, NSC-142693, Polyvidone, Polyvinylpyrrolidone, Polyvinylpyrrolidone [k25, k30, k90], Polyvinylpyrrolidone-(1201)

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

3 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
blepharitis	2	MONDO:0004785	EFO:0009536
viral conjunctivitis	1	MONDO:0043541	EFO:0008571

1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.

Clinical trials

Total trials: 10.

Phase distribution

Phase	Trials
Not specified	4
PHASE2	2
PHASE1/PHASE2	2
PHASE4	1
PHASE3	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00135824	PHASE4	COMPLETED	Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT05668455	PHASE3	RECRUITING	Comparison of Topical Treatment for Inflammatory Secretions of the Conjonctiva (Patients With Ocular Prostheses)
NCT01089608	PHASE2	COMPLETED	Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
NCT04041856	PHASE1/PHASE2	UNKNOWN	Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT05287425	PHASE2	COMPLETED	The Effect of Antibiotic Eye Drops on the Nasal Microbiome in Healthy Subjects
NCT06656169	PHASE1/PHASE2	COMPLETED	Effect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.
NCT01741649	Not specified	COMPLETED	Clorhexidine Versus Povidone for the Prevention of Surgical Site Infection After Cesarean Section
NCT01870583	Not specified	COMPLETED	Comparison of Surgical Skin Preps During Cesarean Deliveries
NCT02908282	Not specified	COMPLETED	Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye
NCT06610331	Not specified	COMPLETED	EVALUATION OF THE EFFECT OF POLYVINYLPYROLIDONE AND SODIUM HYALURONATE GEL ON PALATINAL WOUND HEALING

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).